Mounjaro causes constipation by slowing down how quickly your stomach empties food into your intestines. This delay keeps food sitting in your digestive tract longer than usual, which draws out more water from stool as it moves through the colon and creates a backup. About 1 in 13 people taking Mounjaro experience constipation, making it one of the more common side effects.
How Mounjaro Slows Your Gut
Mounjaro (tirzepatide) works by activating two hormone receptors in your body: GLP-1 and GIP. While both play roles in blood sugar control and appetite, the constipation problem traces specifically to the GLP-1 side. GLP-1 receptors are found throughout the gastrointestinal tract and nervous system. When Mounjaro activates them, one of the effects is a significant slowdown in gastric emptying, the process by which your stomach pushes partially digested food into the small intestine.
This slowdown is actually part of how the drug works. By keeping food in your stomach longer, Mounjaro blunts the spike in blood sugar you’d normally get after a meal and helps you feel full on less food. But the trade-off is that everything downstream moves more slowly too. When stool spends extra time in your colon, the colon keeps absorbing water from it, leaving it harder and more difficult to pass.
When Constipation Is Worst
The gastric slowing effect is strongest when you first start taking Mounjaro and again each time your dose increases. This means constipation tends to flare during the early weeks of treatment and at each step up in the titration schedule. The effect does diminish as your body adjusts, which is why the standard protocol starts at a low dose and increases gradually over several months.
Clinical trial data from a meta-analysis of multiple studies shows the constipation rate across doses was relatively consistent: roughly 1.4% at the 5 mg dose, 2% at 10 mg, and 1.8% at 15 mg. The overall constipation rate for people on tirzepatide was about 2.5%, compared to less than 1% in people taking a placebo, making it about three times more likely with the medication. WebMD reports a somewhat higher real-world figure of about 1 in 13 users, which may reflect the difference between controlled trial reporting and everyday experience.
For most people, gastrointestinal side effects are mild to moderate and improve once the body adapts to each new dose level.
What Helps With Mounjaro Constipation
There are no formal clinical guidelines specifically for treating Mounjaro-related constipation, but the American College of Gastroenterology recommends osmotic laxatives as a suitable first option for mild constipation from GLP-1 medications. Osmotic laxatives work by pulling extra water into your intestines, which softens the stool and makes it easier to pass. Common over-the-counter options include MiraLAX and Milk of Magnesia.
Other options that may help include stool softeners like Colace, stimulant laxatives like Senna or Dulcolax, and magnesium citrate. Since the root cause is slower transit through your gut, practical habits matter too. Staying well hydrated is especially important because your colon is absorbing more water than usual from stool. Fiber-rich foods and regular physical activity both help keep things moving, though adding too much fiber without enough water can actually make constipation worse.
When Constipation Becomes Serious
Most Mounjaro-related constipation is uncomfortable but manageable. However, the FDA’s prescribing label flags some rare but serious gastrointestinal complications that have been reported after the drug went on the market. These include severe constipation leading to fecal impaction, ileus (where the intestines temporarily stop moving), and intestinal obstruction. These are uncommon, but they underscore why persistent or worsening constipation shouldn’t be ignored.
Signs that constipation has moved beyond the “normal side effect” category include not having a bowel movement for several days despite trying laxatives, significant bloating or abdominal distension, vomiting, or severe abdominal pain. If you stop passing both stool and gas, that combination can signal a bowel obstruction, which needs immediate medical attention. The FDA label also notes that Mounjaro is not recommended for people with severe gastroparesis, a condition where the stomach already empties abnormally slowly.
Why It Affects Some People More Than Others
Not everyone on Mounjaro gets constipated, and the severity varies widely. People who were already prone to constipation before starting the medication, whether from diet, low activity levels, or other medications, tend to notice it more. Dehydration amplifies the problem because your body has less water available to keep stool soft. Eating significantly less food, which is common on Mounjaro since it suppresses appetite, also means less bulk moving through the colon, which can slow transit further.
The good news is that the gastric emptying delay, the core mechanism behind the constipation, is most pronounced early in treatment and fades with continued use. Many people find that constipation improves substantially within a few weeks at each dose, even without changing anything else. If it persists, adjusting hydration, fiber intake, and adding an osmotic laxative is usually enough to manage it while your body catches up.